EMA policy on allowing access to EudraVigilance data imminent
This article was originally published in SRA
Executive Summary
The European Medicines Agency has finalised its policy on the different levels of access it will allow to the European pharmacovigilance database (EudraVigilance) and will publish it on its website next week, the agency revealed on 29 June at a press conference in London, UK1,2.